Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial El Saghir N Presentation # 1063 – PosterJune 4, 2023 | …
We are proud to share that 75% of our outstanding medical students have successfully matched with top residency programs on Match Day…
‘Show me my way in life and I will build you a shrine,’ actor Danny Thomas prayed to St Jude Thaddeus in a plea that…
مؤتمر طبي في بيروت: نهاية زمن العلاج الكيميائي؟
This year’s recipients were indeed distinguished leaders in their fields and have dedicated their careers to improve diagnosis, outcomes, and quality of life as well…
Children in the Gaza Strip under the age of 5 — about 335,000 kids — are at high risk of severe malnutrition and preventable death, as the…
Welcome to Best of ASCO – Lebanon! The Best of ASCO have been held annually in Lebanon since 2006. These meetings serve as a vital…
Welcome to Best of ASCO – Lebanon! The Best of ASCO have been held annually in Lebanon since 2006. These meetings serve as a vital…
Article: Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management
The 2023 Beirut Breast Cancer Conference featured four tumor board sessions, a high-profile Opening Session panel debate, and a Closing Ceremony that included a piano…
